首页> 外文OA文献 >Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression
【2h】

Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression

机译:单独分析人乳头瘤病毒E6和E7 Messenger RNA,以预测颈椎瘤瘤进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A few studies previously suggested that human papillomavirus (HPV) E6 messenger RNA (mRNA) may exist uniformly in all grades of cervical intraepithelial neoplasia (CIN), whereas the detection rate of E7 mRNA may increase with disease progression from low-grade CIN to invasive carcinoma. The aim of this study was to clarify the different roles of E6 and E7 mRNAs in cervical carcinogenesis. The presence of each E6 and E7 mRNA was analyzed in 171 patients with pathologically-diagnosed CIN or cervical carcinoma. We utilized a RT-PCR assay based on consensus primers which could detect E6 mRNA (full-length E6/E7 transcript) and E7 mRNAs (spliced E6*/E7 transcripts) separately for various HPV types. E7 mRNAs were detected in 6% of CIN1, 12% of CIN2, 24% of CIN3, and 54% of cervical carcinoma. The presence of E7 mRNAs was significantly associated with progression from low-grade CIN to invasive carcinoma in contrast with E6 mRNA or high-risk HPV (HR-HPV) DNA (p = 0.00011, 0.80 and 0.54). The presence of both E6 and E7 mRNAs was significantly associated with HPV16/18 DNA but not with HR-HPV DNA (p = 0.0079 and 0.21), while the presence of E6 mRNA was significantly associated with HR-HPV DNA but not with HPV16/18 DNA (p = 0.036 and 0.089). The presence of both E6 and E7 mRNAs showed high specificity and low sensitivity (100% and 19%) for detecting CIN2+ by contrast with the positivity for HR-HPV DNA showing low specificity and high sensitivity (19% and 89%). The positive predictive value for detecting CIN2+ was even higher by the presence of both E6 and E7 mRNAs than by the positivity for HR-HPV DNA (100% vs. 91%). In 31 patients followed up for CIN1-2, the presence of both E6 and E7 mRNAs showed significant association with the occurrence of upgraded abnormal cytology in contrast with E6 mRNA, HR-HPV DNA, or HPV16/18 DNA (p = 0.034, 0.73, 0.53, and 0.72). Our findings support previous studies according to which E7 mRNA is more closely involved in cervical carcinogenesis than E6 mRNA. Moreover, the separate analysis of E6 and E7 mRNAs may be more useful than HR-HPV DNA test for detecting CIN2+ precisely and predicting disease progression. Further accumulation of evidence is warranted to validate our findings.
机译:若有的一些研究表明,在宫颈上皮内瘤瘤(CIN)的所有等级中,人乳头瘤病毒(HPV)E6信使RNA(mRNA)可能均匀地存在,而E7 mRNA的检测率可能随疾病的疾病从低级CIN疾病进展增加给侵袭性癌。本研究的目的是阐明E6和E7 mRNA在宫颈发生中的不同作用。在171例病理诊断的CIN或宫颈癌患者中分析了每个E6和E7 mRNA的存在。我们利用基于共有引物的RT-PCR测定,其可以分别检测E6 mRNA(全长E6 / E7转录物)和E7 mRNA(剪接E6 * / E7转录物),以分别用于各种HPV类型。 E7 MRNA在CIN1的6%,12%的CIN2,24%的CIN3和54%的宫颈癌中检测到MRNA。与E6 mRNA或高风险HPV(HR-HPV)DNA相比,E7 mRNA对侵入性癌的进展显着与侵入性癌的存在显着相关(P = 0.00011,0.80和0.54)。 E6和E7 mRNA的存在与HPV16 / 18 DNA显着相关,但不具有HR-HPV DNA(P = 0.0079和0.21),而E6 mRNA的存在显着与HPV DNA显着相关,但不具有HPV16 / 18 DNA(P = 0.036和0.089)。 E6和E7 mRNA的存在表现出高特异性和低灵敏度(100%和19%),用于检测CIN2 +,与HR-HPV DNA的阳性显示出低特异性和高灵敏度(19%和89%)。通过E6和E7MRNA的存在而不是通过HR-HPV DNA的阳性(100%与91%),检测CIN2 +的阳性预测值甚至更高。在31例患者中,随访CIN1-2,E6和E7 MRNA的存在与E6 mRNA,HR-HPV DNA或HPV16 / 18 DNA形成较升级的异常细胞学的发生显着相关(P = 0.034,0.73 ,0.53和0.72)。我们的研究结果支持以前的研究,根据其比E6 mRNA更紧密地参与宫颈癌。此外,E6和E7 mRNA的单独分析可能比HR-HPV DNA测试更有用,用于检测CIN2 +精确和预测疾病进展。有权进一步积累证据以验证我们的调查结果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号